- Home
- FTK vs ATTO Comparison
FTK vs ATTO Comparison
Compare FTK & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTK | ATTO |
|---|---|---|
| Founded | 1985 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1997 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FTK | ATTO |
|---|---|---|
| Price | $26.16 | $15.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $38.92 | ★ $42.20 |
| AVG Volume (30 Days) | 378.9K | ★ 397.2K |
| Earning Date | 11-03-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.06 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $136,092,000.00 | N/A |
| Revenue This Year | $53.24 | N/A |
| Revenue Next Year | $10.87 | N/A |
| P/E Ratio | $68.13 | ★ N/A |
| Revenue Growth | ★ 214.53 | N/A |
| 52 Week Low | $13.19 | $12.94 |
| 52 Week High | $39.67 | $28.00 |
Technical Indicators
Market Signals| Indicator | FTK | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 46.49 |
| Support Level | $21.62 | $13.24 |
| Resistance Level | $28.50 | $18.38 |
| Average True Range (ATR) | 1.29 | 1.27 |
| MACD | 0.03 | 0.26 |
| Stochastic Oscillator | 69.22 | 69.12 |
Price Performance
Historical ComparisonAbout FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.